Ad copy

If your actinic keratosis patches keep returning on schedule, your dermatologist should be having a very different conversation with you. Most aren't. I've been measuring subclinical AK field activity for 19 years. And what I see most often in women over 60 who've been on the quarterly freeze schedule for years? A field that is deeply established and actively generating. That means the field generating your patches is producing new lesions on a predictable schedule that no freeze session is going to interrupt. And most of these women have been told the same thing for years. "Come back in three months. We'll freeze the next ones." My name is Dr. Linda Reyes. I'm a board-certified dermatologist. And I need to tell you what your patch history actually means — and what your dermatologist is probably not measuring at all. --- What subclinical field activity looks like. Most dermatologists measure what they can see. Visible patches. Raised lesions. Sites on the watch list. What they're not measuring is subclinical field activity — the UV-damaged keratinocyte field spreading invisibly through the dermis beneath every patch you can see and beneath the skin that looks completely clear around it. That field is the source. The visible patches are the endpoint. When I assess a patient's subclinical field activity, I look for two things immediately: One — how long the field has been active, which is often far longer than the visible patches suggest. Two — whether freeze sessions are managing the endpoints or actually touching the source. An early-stage field means new patches will appear in skin that looks completely clear today. The quarterly appointment schedule is already behind the field's progression. A deeply established field means standard dermatology protocols — freeze sessions, diclofenac, even field chemotherapy — have very limited effect. Because none of those treatments were designed to reach the dermis where the field lives. Most of my new patients who've been on the quarterly freeze schedule for years come in with fields that have been generating for a long time. They've been doing everything right for years. Perfect compliance. Never missed an appointment. And the field keeps advancing. --- Why the field keeps advancing despite perfect treatment. The subclinical field lives in the dermis. The deep skin layer. Below the stratum corneum — the outermost lipid barrier your skin uses to keep water out and moisture in. Freeze sessions destroy visible patches. They target the surface. They were never designed to penetrate the stratum corneum and reach the dermis where the field is generating. Diclofenac is water-based. Water cannot cross a lipid barrier. Less than 4% of any water-based compound reaches the dermis. The field lives in the remaining 96%. 5-fluorouracil field therapy forces surface cell turnover. The dermis underneath remains untouched. New patches appear at the edges of the treated zone because the field never stopped generating. Every treatment your dermatologist has prescribed was designed for the surface. Your field lives underneath it. That's why new patches keep appearing in skin that looked clear last visit. That's why perfect compliance for years produces a field that is more established than when you started. The fire is in the basement. We've been painting the ground floor. --- What actually reaches the dermis. This is what I explain to every patient whose field has been advancing despite consistent treatment. The stratum corneum is a lipid barrier. Oil-based by design. Water-based compounds bounce off it. Lipid-based compounds cross it. Cold-pressed camellia oil and sea buckthorn oil are lipid carriers with the molecular structure to penetrate all seven skin layers and deliver oil-soluble actives to the dermis. Right to where the subclinical field lives. Oil-soluble vitamin C — ascorbyl tetraisopalmitate, not ascorbic acid — carried through the stratum corneum by the camellia and sea buckthorn. Directly neutralizing the UV-induced oxidative cascade driving abnormal keratinocyte proliferation. In the dermis. On the field. Bakuchiol at clinical concentration supporting normal keratinocyte cycling — replacing the abnormal misfiring proliferation with healthy cell renewal. From the dermis out. Zero water in the formula. Because every drop of water competes with the lipid carrier for penetration. Everything oil-soluble. Everything lipid-delivered. Everything reaching the field. When I assess a patient's subclinical field activity after 12 weeks of consistent morning and evening lipid-delivered botanical application, what I observe looks very different. --- What I see after 12 weeks. Patient. 67 years old. Nine years on the quarterly freeze schedule. Field deeply established across both forearms, hands, upper arms. Her previous dermatologist had recommended photodynamic therapy and field chemotherapy. She came to me for a second opinion. I assessed her field activity. Explained what I was seeing. Recommended 12 weeks of lipid-delivered botanical field support before making any escalation decisions. She was skeptical. Nine years of perfect freeze compliance hadn't changed anything. She didn't believe applying oil morning and evening could change what nine years of liquid nitrogen hadn't. I explained it simply. Nine years of liquid nitrogen destroyed the surface endpoints. Zero minutes of that time reached the dermis where the field was generating. You haven't failed the protocol. The protocol failed to reach the problem. At week 12, her field activity was measurably calmer. Surface lesion activity had reduced noticeably across previously active sites. New lesion generation at sites that had been producing on schedule every quarter: significantly reduced. She revisited the escalation conversation with her previous dermatologist at her next appointment. She sat in my office looking at her forearms for a long time. "Why didn't anyone address this before?" I didn't have a good answer. --- What your patch history is probably telling you. If you've been on the quarterly freeze schedule for more than two years and new patches keep appearing at every visit — your field has been generating longer than you think. If you've been on the schedule for more than four years — the field is established. If your dermatologist has mentioned field chemotherapy or photodynamic therapy — the field has been advancing for years. If you've already done field chemotherapy and new patches appeared at the edges of the treated area — the field was never reached. You don't need a device to know this. Your patch history tells the story. Every quarter with a new patch is another quarter the field recruited surrounding tissue. Every year the field becomes more established, more resistant to surface treatment, more difficult to address. The window for the most effective field intervention is before the field is so deeply established that even lipid-delivered actives need multiple cycles to reach it. If you're reading this and your patches have been spreading for years, that window is still open. But it closes. --- The product I share with patients. Dermiqua. Cold-pressed camellia and sea buckthorn oil as the lipid carrier. Oil-soluble vitamin C at clinical concentration. Bakuchiol for natural cellular turnover. Sixteen botanicals. Zero water. Zero filler. Applied morning and evening — because the field doesn't rest. $44.95 a bottle. 90-day money-back guarantee. If your patches aren't calming — if the rough texture isn't smoothing, if the raised edges aren't flattening, if new lesions are still appearing on the same quarterly schedule — every penny back. I have no financial relationship with this company. I share it because the mechanism matches the biology, the research supports it, and I've watched field activity calm in patients whose fields had been advancing for years. Your dermatologist is measuring the endpoints. Nobody is measuring the field. Now you know what your patch history is telling you. And you know what reaches it. 👉 dermiqua.com/pages/actinic-keratosis — Dr. Linda Reyes, MD Board-Certified Dermatologist P.S. — If your field has been active for years, standard protocols have very limited effect on what's generating underneath. Most women who've been on the quarterly freeze schedule for years have a field that has been advancing the entire time. They just don't know it because nobody looked there. Now you do. P.P.S. — Every quarter on the freeze schedule without addressing the field is another quarter the field advances. Every year it becomes more established. The window for the most effective intervention closes gradually, then quickly. Don't wait until the field is too deeply established to address efficiently. P.P.P.S. — My patient with the deeply established field cancelled her escalation appointments. Nine years of freeze sessions never reached the source. Twelve weeks of morning and evening lipid-delivered oil did. The field was reachable the whole time. The delivery system just wasn't right.